ADMP Annual EBIT
-$25.06 M
+$9.53 M+27.56%
31 December 2022
Summary:
As of February 5, 2025, ADMP annual earnings before interest & taxes is -$25.06 million, with the most recent change of +$9.53 million (+27.56%) on December 31, 2022. During the last 3 years, it has risen by +$2.32 million (+8.48%).ADMP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP Quarterly EBIT
-$6.96 M
-$529.40 K-8.24%
30 June 2023
Summary:
As of February 5, 2025, ADMP quarterly earnings before interest & taxes is -$6.96 million, with the most recent change of -$529.40 thousand (-8.24%) on June 30, 2023. Over the past year, it has increased by +$1.38 million (+16.54%).ADMP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP TTM EBIT
-$20.30 M
+$1.38 M+6.36%
30 June 2023
Summary:
As of February 5, 2025, ADMP TTM earnings before interest & taxes is -$20.30 million, with the most recent change of +$1.38 million (+6.36%) on June 30, 2023. Over the past year, it has increased by +$6.41 million (+23.99%).ADMP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.6% | +16.5% | +24.0% |
| 3 y3 years | +8.5% | +46.0% | +34.3% |
| 5 y5 years | +2.3% | +27.9% | +25.9% |
ADMP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -3369.7% | -241.7% | -2161.1% |
Adamis Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$6.96 M(+8.2%) | -$20.30 M(-6.4%) |
| Mar 2023 | - | -$6.43 M(+143.3%) | -$21.68 M(-6.4%) |
| Dec 2022 | -$25.06 M(-27.6%) | -$2.64 M(-38.1%) | -$23.16 M(-10.3%) |
| Sept 2022 | - | -$4.27 M(-48.8%) | -$25.81 M(-3.4%) |
| June 2022 | - | -$8.34 M(+5.3%) | -$26.70 M(+2.5%) |
| Mar 2022 | - | -$7.91 M(+49.6%) | -$26.06 M(-18.6%) |
| Dec 2021 | -$34.59 M(-3.5%) | -$5.29 M(+2.4%) | -$32.01 M(-17.0%) |
| Sept 2021 | - | -$5.17 M(-32.8%) | -$38.59 M(-11.1%) |
| June 2021 | - | -$7.69 M(-44.5%) | -$43.42 M(-10.7%) |
| Mar 2021 | - | -$13.86 M(+16.8%) | -$48.62 M(+15.9%) |
| Dec 2020 | -$35.84 M(+30.9%) | -$11.87 M(+18.7%) | -$41.97 M(+23.7%) |
| Sept 2020 | - | -$10.00 M(-22.4%) | -$33.93 M(+9.8%) |
| June 2020 | - | -$12.89 M(+78.9%) | -$30.90 M(+20.1%) |
| Mar 2020 | - | -$7.21 M(+88.3%) | -$25.73 M(-6.0%) |
| Dec 2019 | -$27.38 M(-30.2%) | -$3.83 M(-45.2%) | -$27.38 M(-25.4%) |
| Sept 2019 | - | -$6.98 M(-9.5%) | -$36.71 M(-4.8%) |
| June 2019 | - | -$7.71 M(-13.0%) | -$38.58 M(-4.8%) |
| Mar 2019 | - | -$8.86 M(-32.6%) | -$40.51 M(+3.3%) |
| Dec 2018 | -$39.22 M(+52.9%) | -$13.16 M(+48.7%) | -$39.22 M(+14.1%) |
| Sept 2018 | - | -$8.84 M(-8.4%) | -$34.38 M(+6.6%) |
| June 2018 | - | -$9.65 M(+27.5%) | -$32.25 M(+17.2%) |
| Mar 2018 | - | -$7.57 M(-9.0%) | -$27.51 M(+7.3%) |
| Dec 2017 | -$25.65 M(+7.8%) | -$8.31 M(+23.8%) | -$25.65 M(+14.0%) |
| Sept 2017 | - | -$6.72 M(+36.7%) | -$22.51 M(+0.6%) |
| June 2017 | - | -$4.91 M(-13.9%) | -$22.36 M(-3.2%) |
| Mar 2017 | - | -$5.71 M(+10.3%) | -$23.09 M(-1.3%) |
| Dec 2016 | -$23.80 M(+71.8%) | -$5.17 M(-21.3%) | -$23.41 M(+11.0%) |
| Sept 2016 | - | -$6.57 M(+16.5%) | -$21.10 M(+18.3%) |
| June 2016 | - | -$5.64 M(-6.2%) | -$17.83 M(+13.4%) |
| Mar 2016 | - | -$6.02 M(+110.2%) | -$15.72 M(+13.5%) |
| Dec 2015 | -$13.85 M(+52.4%) | -$2.86 M(-13.5%) | -$13.85 M(+26.1%) |
| Sept 2015 | - | -$3.31 M(-6.3%) | -$10.99 M(+12.1%) |
| June 2015 | - | -$3.53 M(-14.9%) | -$9.80 M(+9.8%) |
| Mar 2015 | - | -$4.15 M(+95.3%) | -$8.93 M(+39.1%) |
| Dec 2014 | -$9.09 M(-2032.8%) | - | - |
| Sept 2014 | - | -$2.12 M(-20.0%) | -$6.42 M(+314.7%) |
| June 2014 | - | -$2.66 M(+88.7%) | -$1.55 M(-429.0%) |
| Mar 2014 | $470.30 K(-109.9%) | -$1.41 M(+509.3%) | $470.30 K(-52.2%) |
| Dec 2013 | - | -$230.90 K(-108.4%) | $984.80 K(+1034.6%) |
| Sept 2013 | - | $2.75 M(-530.6%) | $86.80 K(-103.0%) |
| June 2013 | - | -$637.60 K(-28.5%) | -$2.94 M(-37.9%) |
| Mar 2013 | -$4.73 M(-1.6%) | -$892.30 K(-21.0%) | -$4.73 M(-4.8%) |
| Dec 2012 | - | -$1.13 M(+305.9%) | -$4.97 M(+2.9%) |
| Sept 2012 | - | -$278.10 K(-88.6%) | -$4.83 M(-19.9%) |
| June 2012 | - | -$2.43 M(+114.5%) | -$6.03 M(+25.3%) |
| Mar 2012 | -$4.81 M(-22.9%) | -$1.13 M(+14.6%) | -$4.82 M(+0.3%) |
| Dec 2011 | - | -$988.70 K(-33.2%) | -$4.80 M(-29.7%) |
| Sept 2011 | - | -$1.48 M(+22.1%) | -$6.83 M(+5.7%) |
| June 2011 | - | -$1.21 M(+8.5%) | -$6.46 M(+3.6%) |
| Mar 2011 | -$6.24 M(+56.8%) | -$1.12 M(-63.0%) | -$6.24 M(-13.3%) |
| Dec 2010 | - | -$3.02 M(+171.6%) | -$7.20 M(+47.9%) |
| Sept 2010 | - | -$1.11 M(+12.5%) | -$4.87 M(+13.5%) |
| June 2010 | - | -$989.10 K(-52.3%) | -$4.29 M(+7.7%) |
| Mar 2010 | -$3.98 M | -$2.07 M(+199.4%) | -$3.98 M(+78.7%) |
| Dec 2009 | - | -$692.30 K(+30.2%) | -$2.23 M(+24.1%) |
| Sept 2009 | - | -$531.80 K(-22.3%) | -$1.79 M(+17.7%) |
| June 2009 | - | -$684.30 K(+114.5%) | -$1.52 M(+29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | -$319.00 K(+23.1%) | -$1.18 M(-11.1%) |
| Dec 2008 | -$1.32 M(-27.4%) | -$259.10 K(-1.1%) | -$1.32 M(-12.8%) |
| Sept 2008 | - | -$262.00 K(-21.8%) | -$1.52 M(-8.7%) |
| June 2008 | - | -$335.00 K(-28.0%) | -$1.66 M(-6.0%) |
| Mar 2008 | - | -$465.00 K(+2.5%) | -$1.77 M(-3.1%) |
| Dec 2007 | -$1.82 M(-61.1%) | -$453.60 K(+11.7%) | -$1.82 M(+31.5%) |
| Sept 2007 | - | -$406.00 K(-7.9%) | -$1.39 M(-41.7%) |
| June 2007 | - | -$441.00 K(-15.4%) | -$2.38 M(-20.3%) |
| Mar 2007 | - | -$521.00 K(+2843.5%) | -$2.98 M(-34.5%) |
| Dec 2006 | -$4.69 M(-12.5%) | -$17.70 K(-98.7%) | -$4.55 M(-33.4%) |
| Sept 2006 | - | -$1.40 M(+33.7%) | -$6.84 M(-15.8%) |
| June 2006 | - | -$1.04 M(-50.0%) | -$8.12 M(+275.8%) |
| Mar 2006 | - | -$2.09 M(-9.2%) | -$2.16 M(-59.1%) |
| Dec 2005 | -$5.36 M(-61.7%) | -$2.30 M(-13.9%) | -$5.28 M(-31.5%) |
| Sept 2005 | - | -$2.68 M(-154.5%) | -$7.70 M(-6.3%) |
| June 2005 | - | $4.91 M(-194.3%) | -$8.22 M(-48.5%) |
| Mar 2005 | - | -$5.21 M(+10.3%) | -$15.97 M(+14.0%) |
| Dec 2004 | -$14.00 M(+0.8%) | -$4.72 M(+47.9%) | -$14.00 M(+8.9%) |
| Sept 2004 | - | -$3.19 M(+12.6%) | -$12.86 M(+3.2%) |
| June 2004 | - | -$2.84 M(-12.6%) | -$12.46 M(-13.4%) |
| Mar 2004 | - | -$3.25 M(-9.3%) | -$14.39 M(+4.4%) |
| Dec 2003 | -$13.89 M(-15.6%) | -$3.58 M(+27.8%) | -$13.79 M(-5.0%) |
| Sept 2003 | - | -$2.80 M(-41.3%) | -$14.51 M(+7.8%) |
| June 2003 | - | -$4.77 M(+80.9%) | -$13.47 M(-6.8%) |
| Mar 2003 | - | -$2.64 M(-38.8%) | -$14.45 M(-12.2%) |
| Dec 2002 | -$16.46 M(-5.8%) | -$4.31 M(+145.2%) | -$16.46 M(-2.5%) |
| Sept 2002 | - | -$1.76 M(-69.5%) | -$16.87 M(-12.6%) |
| June 2002 | - | -$5.75 M(+23.9%) | -$19.30 M(+7.8%) |
| Mar 2002 | - | -$4.64 M(-1.7%) | -$17.90 M(+2.5%) |
| Dec 2001 | -$17.46 M(+49.4%) | -$4.72 M(+12.9%) | -$17.46 M(+5.2%) |
| Sept 2001 | - | -$4.18 M(-3.9%) | -$16.60 M(+7.8%) |
| June 2001 | - | -$4.35 M(+3.5%) | -$15.40 M(+10.7%) |
| Mar 2001 | - | -$4.21 M(+9.1%) | -$13.91 M(+19.0%) |
| Dec 2000 | -$11.69 M(+18.6%) | -$3.86 M(+29.0%) | -$11.69 M(+12.5%) |
| Sept 2000 | - | -$2.99 M(+4.3%) | -$10.39 M(+7.4%) |
| June 2000 | - | -$2.86 M(+44.6%) | -$9.67 M(+5.5%) |
| Mar 2000 | - | -$1.98 M(-22.5%) | -$9.17 M(-7.6%) |
| Dec 1999 | -$9.85 M(+16.4%) | -$2.55 M(+12.3%) | -$9.93 M(+3.0%) |
| Sept 1999 | - | -$2.27 M(-3.5%) | -$9.64 M(-0.3%) |
| June 1999 | - | -$2.36 M(-14.0%) | -$9.67 M(-1.5%) |
| Mar 1999 | - | -$2.74 M(+20.8%) | -$9.81 M(+13.2%) |
| Dec 1998 | -$8.47 M(+84.1%) | -$2.27 M(-1.4%) | -$8.67 M(+7.0%) |
| Sept 1998 | - | -$2.30 M(-8.0%) | -$8.10 M(+20.9%) |
| June 1998 | - | -$2.50 M(+56.3%) | -$6.70 M(+28.8%) |
| Mar 1998 | - | -$1.60 M(-5.9%) | -$5.20 M(+13.0%) |
| Dec 1997 | -$4.60 M(+24.3%) | -$1.70 M(+88.9%) | -$4.60 M(+24.3%) |
| Sept 1997 | - | -$900.00 K(-10.0%) | -$3.70 M(-2.6%) |
| June 1997 | - | -$1.00 M(0.0%) | -$3.80 M(+2.7%) |
| Mar 1997 | - | -$1.00 M(+25.0%) | -$3.70 M(+5.7%) |
| Dec 1996 | -$3.70 M(+146.7%) | -$800.00 K(-20.0%) | -$3.50 M(-5.4%) |
| Sept 1996 | - | -$1.00 M(+11.1%) | -$3.70 M(+19.4%) |
| June 1996 | - | -$900.00 K(+12.5%) | -$3.10 M(+82.4%) |
| Mar 1996 | - | -$800.00 K(-20.0%) | -$1.70 M(+112.5%) |
| Dec 1995 | -$1.50 M | -$1.00 M(+150.0%) | -$800.00 K(-500.0%) |
| Sept 1995 | - | -$400.00 K(-180.0%) | $200.00 K(-66.7%) |
| June 1995 | - | $500.00 K(+400.0%) | $600.00 K(+500.0%) |
| Mar 1995 | - | $100.00 K | $100.00 K |
FAQ
- What is Adamis Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual EBIT year-on-year change?
- What is Adamis Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly EBIT year-on-year change?
- What is Adamis Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals TTM EBIT year-on-year change?
What is Adamis Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ADMP is -$25.06 M
What is the all time high annual EBIT for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual earnings before interest & taxes is $766.40 K
What is Adamis Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ADMP annual earnings before interest & taxes has changed by +$9.53 M (+27.56%)
What is Adamis Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ADMP is -$6.96 M
What is the all time high quarterly EBIT for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly earnings before interest & taxes is $4.91 M
What is Adamis Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ADMP quarterly earnings before interest & taxes has changed by +$1.38 M (+16.54%)
What is Adamis Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ADMP is -$20.30 M
What is the all time high TTM EBIT for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high TTM earnings before interest & taxes is $984.80 K
What is Adamis Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ADMP TTM earnings before interest & taxes has changed by +$6.41 M (+23.99%)